Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

VNDA US Equity

Vanda Pharmaceuticals Inc.Health Care · Pharmaceutical Preparations · CIK 1347178 · FY ends Dec 31
$5.57
+0.13 (+2.39%)
USD · as of 2026-08-19 · marketstack

Short interest· FINRA consolidated · settlement 2026-07-31

6 settlement cycles
Shares short7.4M
% of shares out12.3%
Days to cover9.0
Δ vs 2026-07-15+3.3%
▲ 7.4M shares shortline top = 9.0d to cover2026-05-15: 6.4M short · 4.9d to cover2026-052026-05-29: 6.8M short · 6.8d to cover2026-052026-06-15: 7.0M short · 7.8d to cover2026-062026-06-30: 7.3M short · 7.9d to cover2026-062026-07-15: 7.2M short · 8.8d to cover2026-072026-07-31: 7.4M short · 9.0d to cover2026-07

bars = shares short · line = days to cover (own scale)

SettlementShares shortΔ vs priorAvg daily volumeDays to cover
2026-07-317,422,856+3.3%824,8759.0
2026-07-157,188,123-2.1%816,7048.8
2026-06-307,342,818+5.1%932,6977.9
2026-06-156,989,104+2.6%898,4607.8
2026-05-296,811,524+7.0%1,001,7946.8
2026-05-156,368,418+2.8%1,299,9424.9

FINRA Rule 4560 · twice monthly, published ~a week later.

Output of a disclosed model — assumptions may be wrong. Research, not investment advice. See the Disclaimer.